Live-saving medicine needs to be available for all income brackets Photo: CC Tom-Varco Martin Shkreli, the CEO of Turing Pharmaceuticals, bought the rights to Daraprim, a drug that is used to treat toxoplasmosis, some forms of cancer, and HIV/AIDS in late August. On Sept. 21, Shkreli publically announced a price hike from US$13.50 to $750, just …